This inventor holds 3 USPTO granted patents. Top assignee: University of Connecticut. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Willimantic, CT (US) (2019 - 2022)
- Vernon, CT (US) (2024)
Company Filing History:
Years Active: 2019-2024
Title: Charan Devarakonda: Inventor in Biomedical Diagnostics and Therapeutics.
Introduction
Charan Devarakonda is an inventor based in Willimantic, Connecticut, and is associated with the University of Connecticut. His patent work includes biomedical approaches to diagnosing kidney dysfunction and targeting tumor-associated antigens. He is named on 3 patents.
Latest Patents
One of Devarakonda’s latest patents, “Biomarker Panel for Non-Invasive Diagnosis of Congenital Renal Dysfunction,” describes methods and compositions for assessing obstructive renal dysfunction, including ureteropelvic junction obstruction. The approach detects selected proteins, or detectable portions of them, in a urine sample. The biomarkers include ISLR, QPRT, PTGR1, VCAM1, and FCN2, which may help identify a subject at risk of or experiencing the condition.
Another patent, “Antibody and Antigen-Binding Fragment Compositions Targeting Cell Surface Antigens in Tumors and Methods of Use Thereof,” describes an antibody or antigen-binding fragment that specifically binds human HSP90, particularly HSP90 beta. The disclosure also covers methods for detecting and treating conditions using these antibody compositions.
Career Highlights
Devarakonda’s listed patent portfolio reflects work at the intersection of diagnostic biomarkers, antibody engineering, and potential therapeutic applications. His University of Connecticut affiliation connects this research to an academic institution.
Collaborations
The provided information identifies Kevin Patrick Claffey and Daniel Kita as Devarakonda’s coworkers. Their names are associated here as collaborators, although specific roles in the listed patent disclosures were not provided.
Conclusion
Charan Devarakonda’s patent work addresses non-invasive diagnosis of renal dysfunction and antibody-based approaches involving tumor-associated targets, highlighting biomedical innovation connected with the University of Connecticut.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
